Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.

MLA

Andrews, C. N., et al. “Mesalazine (5-Aminosalicylic Acid) Alters Faecal Bacterial Profiles, but Not Mucosal Proteolytic Activity in Diarrhoea-Predominant Irritable Bowel Syndrome.” Alimentary Pharmacology & Therapeutics, vol. 34, no. 3, Aug. 2011, pp. 374–83. EBSCOhost, https://doi.org/10.1111/j.1365-2036.2011.04732.x.

APA

Andrews, C. N., Griffiths, T. A., Kaufman, J., Vergnolle, N., Surette, M. G., & Rioux, K. P. (2011). Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 34(3), 374–383. https://doi.org/10.1111/j.1365-2036.2011.04732.x

Chicago

Andrews, C N, T A Griffiths, J Kaufman, N Vergnolle, M G Surette, and K P Rioux. 2011. “Mesalazine (5-Aminosalicylic Acid) Alters Faecal Bacterial Profiles, but Not Mucosal Proteolytic Activity in Diarrhoea-Predominant Irritable Bowel Syndrome.” Alimentary Pharmacology & Therapeutics 34 (3): 374–83. doi:10.1111/j.1365-2036.2011.04732.x.